Maternal Burnout, Breastfeeding Self-Efficacy and Attachment Level

NCT ID: NCT07112495

Last Updated: 2026-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-01

Study Completion Date

2025-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Labor pain causes women to be afraid of vaginal delivery and to be anxious about delivery and therefore to prefer cesarean delivery (Ali Alahmari et al., 2020). The World Health Organization (WHO) has set the safe cesarean section rate for countries at 15% (World Health Organization, 2015). However, many countries are well above this rate (Betran et al., 2021). An important factor in the preference for cesarean deliveries is the fear of vaginal delivery (Zhao et al., 2021). Vaginal delivery with epidural anesthesia in primiparous women is a very good opportunity to prevent the preference of cesarean deliveries due to fear of vaginal delivery. Unless contraindicated, epidural analgesia should be offered to women to alleviate the pain felt with contractions during labor (Callahan et al., 2023).

Recently, women frequently prefer epidural anesthesia to avoid pain during vaginal delivery. Vaginal delivery with epidural anesthesia aims to minimize the pain of women during the trauma process and is the most effective pain method among pharmacological and nonpharmacological interventions (Antonakou, \& Papoutsis, 2016). The reason why vaginal delivery with epidural anesthesia is not widespread enough is that women are not given enough information about epidural anesthesia (Shishido et al., 2020).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Purpose: The aim of this study is to emphasize the importance of vaginal birth with epidural anesthesia in primiparous women (who will have their first birth) in order to reduce the effect of fear of vaginal birth on the choice of cesarean section and to evaluate the effect of increasing the level of knowledge about epidural anesthesia on birth preferences.

Objectives:

To determine the level of fear and anxiety of women regarding childbirth.

To examine the effect of fear of vaginal birth on the preference for cesarean section.

To evaluate the effectiveness of vaginal birth with epidural anesthesia in pain management.

To determine the level of knowledge of women about epidural anesthesia.

To increase the rate of preference for vaginal birth by providing information about epidural anesthesia.

To reveal the role of widespread use of epidural anesthesia in reducing cesarean section rates.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study was designed as a randomized controlled trial.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention

pregnant women receiving epidural

Group Type EXPERIMENTAL

pregnant women with

Intervention Type OTHER

pregnant women with

Control

no pregnant women receiving epidural

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pregnant women with

pregnant women with

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having a normal vaginal delivery in the delivery room,
* 19 to 45 years old
* To be transferred to the Puerperium service after delivery,
* The baby's APGAR score is 7 and above
* 37 and above weeks of gestation
* No complications in the baby and mother due to childbirth
* Postnatal care by the mother's side
* Mother and baby sharing the same room after birth until discharge,
* The mother is breastfeeding her baby,
* Mother's voluntary participation in the study.

Exclusion Criteria

* Separation of mother and baby for any reason while the mother is with the baby
* Transfer of the baby to the NICU
* Wanting to get out of the study.
* Being a single parent
* Those who cannot speak and write Turkish
Minimum Eligible Age

19 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sakarya University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

öznur tiryaki

Associate Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tiryaki

Role: STUDY_CHAIR

Sakarya

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sakarya University

Sakarya, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OznurT.

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.